PPT-Disease Burden, Costs and Access to Valuable Cancer Medicines: 

how the pandemic has influenced the disease burden Bengt Jönsson Professor emeritus Stockholm School of Economics Wednesday 1 July 2020 16301900 CET online event Launch of the European Parliament  . 1 Epidemiology and Burden of Disease WHO Geneva (EBD/GPE) 2 Dmaternal sepsisft 15 Global Burden of Disease 2000 Steve . MacFeely. Director of Business Statistics & Innovation. Outline of Presentation. 1. CSO . 2. Burden Reduction. 3. Costs. 4. Blockages & Risks. CSO - Mandate. Statistics Act, 1993. To collect, compile, extract and disseminate for statistical purposes, information . The Global Burden of Disease conceptTo use time as a common currency for non-fatal health states and for YLL, time must bedefined and measured for living in non-fatal health states. To place a value Professor Mustafa Idris . Elbashir. MD, PhD. Faculty of Medicine. University of Khartoum, Sudan. mustidris@hotmail.com. mustafa@uofk.edu.sd. Good health is important for building vibrant and productive communities, stronger economies, safer nations, and better world. . Professor Mustafa Idris . Elbashir. MD, PhD. Faculty of Medicine. University of Khartoum, Sudan. mustidris@hotmail.com. mustafa@uofk.edu.sd. Good health is important for building vibrant and productive communities, stronger economies, safer nations, and better world. . WHO EMP and NVI Departments. Access to NCD essential medicines . on the global agenda. Access to chronic disease medicines is required for the fulfilment of MDG8. Governments, in collaboration with the private sector, should give greater priority to treating chronic diseases and improving the accessibility of medicines to treat them (MDG Report 2009). Lower rates of premature death have driven reduction in disease burden in the U.S., after adjusting for age. Age standardized disability adjusted life year (DALY) rate per 100,000 population, 1990 - 2010. 2018 Illinois cancer symposium. Christine Callahan, PhD, LCSW-C. Research Assistant Professor. University of Maryland School of Social Work/Financial Social Work Initiative. FSWI. Some background…. Dr Cécile . Macé. . WHO EMP , Mr Arne-Petter . Sanne. WHO MND, . Mr . Ajuebor. Onyema WHO MND. NCD Programme Managers Seminar. 4 June 2014. Access to NCD essential medicines . on the global agenda. Case Management. George Jagoe . EVP, Access & Product Management, MMV. . . The access team at MMV is heavily focused on the needs of control today. 4. Achieving patient impact means addressing many hurdles to access. The number of cancer cases has increased over the past two decades. Variation remains across Europe with Hungary recording over 50% more cancer cases per 100,000 population than Cyprus.. Hofmarcher. , T et al. (2019) Comparator Report on Cancer in Europe 2019 - Disease Burden, Costs and Access to Medicines. IHE Report 2019:7. IHE: Lund, Sweden. For further information, please follow:  . Once . the protection of the product . expires for . example, patents or regulatory protection such as data . exclusivity, . the company no longer has exclusive rights to sell the medicine. . Other . MacFeely. Director of Business Statistics & Innovation. Outline of Presentation. 1. CSO . 2. Burden Reduction. 3. Costs. 4. Blockages & Risks. CSO - Mandate. Statistics Act, 1993. To collect, compile, extract and disseminate for statistical purposes, information . Dr. Sonalika’s Eye Clinic provide the best Corneal disease treatment in Pune, Hadapsar, Amanora, Magarpatta, Mundhwa, Kharadi Rd, Viman Nagar, Wagholi, and Wadgaon Sheri